Deuterated CFTR potentiators
US-9512079-B2 · Dec 6, 2016 · US
with oxygen atoms in position 4
with oxygen atoms in position 4 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D215/56 |
| Official title | with oxygen atoms in position 4 |
| Display label | with oxygen atoms in position 4 |
| Total patents | 217 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 38 |
| 2016 | 26 |
| 2017 | 25 |
| 2018 | 18 |
| 2019 | 21 |
| 2020 | 19 |
| 2021 | 24 |
| 2022 | 17 |
| 2023 | 10 |
| 2024 | 10 |
| 2025 | 7 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Quinolone compound
US-2016340314-A1 · Nov 24, 2016 · US
Modulators of atp-binding cassette transporters
US-2016318931-A1 · Nov 3, 2016 · US
Treatment of crohn's disease with laquinimod
US-2016296512-A1 · Oct 13, 2016 · US
Solid Forms of Ivacaftor and Processes for the Preparation Thereof
US-2016280654-A1 · Sep 29, 2016 · US
5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof
US-2016279121-A1 · Sep 29, 2016 · US
Quinolone compound
US-9440951-B2 · Sep 13, 2016 · US
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US-2016229806-A1 · Aug 11, 2016 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2016221952-A1 · Aug 4, 2016 · US
Heterocyclic compound and use therefor
US-9403802-B2 · Aug 2, 2016 · US
Antibiotic conjugates directly linked with steroid drugs
US-9402912-B2 · Aug 2, 2016 · US
T-box riboswitch-binding anti-bacterial compounds
US-2016194317-A1 · Jul 7, 2016 · US
Process for making modulators of cystic fibrosis transmembrane conductance regulator
US-9371287-B2 · Jun 21, 2016 · US
Crystals of laquinimod sodium and improved process for the manufacture thereof
US-2016158216-A1 · Jun 9, 2016 · US
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
US-2016151345-A1 · Jun 2, 2016 · US
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
US-2016151346-A1 · Jun 2, 2016 · US
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
US-2016096807-A1 · Apr 7, 2016 · US
N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
US-9284276-B2 · Mar 15, 2016 · US
2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient
US-9266872-B2 · Feb 23, 2016 · US
Crystals of laquinimod sodium and improved process for the manufacture thereof
US-2016046582-A1 · Feb 18, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D215/56?
- CPC C07D215/56 is the Cooperative Patent Classification code for “with oxygen atoms in position 4.”
- How many patents are filed under CPC C07D215/56 (with oxygen atoms in position 4)?
- Our database includes 217 publications tagged with this CPC code.
- Is patent activity under CPC C07D215/56 growing?
- Publication counts under this code: 10 in 2024 vs 7 in 2025 (latest complete years).